ISSN 1016-5169 | E-ISSN 1308-4488
Archives of the Turkish Society of Cardiology
Evaluation using the Umea 22 questionnaire of quality of life among patients with atrioventricular nodal tachycardia undergoing successful radiofrequency ablation treatment [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2015; 43(4): 356-360 | DOI: 10.5543/tkda.2015.14719

Evaluation using the Umea 22 questionnaire of quality of life among patients with atrioventricular nodal tachycardia undergoing successful radiofrequency ablation treatment

Sadık Volkan Emren1, Uğur Kocabaş2, Selcen Yakar Tülüce2, Ersin Çağrı Şimşek2, Eser Varış2, Hamza Duygu2, Nihan Kahya Eren2, Zehra İlke Akyıldız2, Serhan Özyıldırım2, Cem Nazlı2, Zeynep Yapan Emren3
1Afyonkarahisar State Hospital, Cardiology Clinic, Afyonkarahisar, Turkey
2Katip Celebi University, Atatürk Training And Research Hospital, Cardiology Clinic, Izmir, Turkey
3Sandıklı State Hospital, Cardiology Clinic, Afyonkarahisar, Turkey


OBJECTIVE
Atrioventricular nodal reentrant tachycardia (AVNRT) attacks is one of the common arrhythmias adversely affecting quality of life. The Umea 22 (U22) is a questionnaire developed for the assessment of symptoms associated with supraventricular tachycardia (SVT), and it is found to be effective in evaluation of quality of life after radiofrequency ablation. Using this questionnaire, the study aimed to assess quality of life among Turkish patients with ANRT before and after the successful RFA.

METHODS
The study was conducted between January 2011 and September 2013, and included 57 patients who had undergone RFA due to AVNRT. The U22 questionnaire was administered pre-procedure and at 6 months post-procedure. The participants were asked to report on their general wellbeing, arrhythmia effects on their wellbeing, and intensity of discomfort associated with episodes. They were asked to provide a score from 1 to 10 in order to determine to severity of discomfort, and the quantity of symptoms was then assessed according to the visual analogue scale (VAS).

RESULTS
Patients’ general wellbeing (7.5±2.3 vs. 8.7±1.8, p<0.001), the effects of arrhythmia episodes on general wellbeing (8.1±1.7 vs. 1.0±2.1, p<0.001), frequency of symptoms (2.8±0.8 vs. 0.4±0.9, p<0.001) and duration of symptoms were reduced significantly after RFA. The rate of drug use among patients also decreased after RFA (70% vs. 23%, p=0.017).

CONCLUSION
Treatment success was high in patients undergoing RFA due to AVNRT according to the U22 quality of life questionnaire. General and arrhythmia-associated quality of life had improved significantly by the 6th month post-procedure.

Keywords: Electrocardiography, heart conduction system; catheter ablation; tachycardia, atrioventricular nodal reentry; quality of life

How to cite this article
Sadık Volkan Emren, Uğur Kocabaş, Selcen Yakar Tülüce, Ersin Çağrı Şimşek, Eser Varış, Hamza Duygu, Nihan Kahya Eren, Zehra İlke Akyıldız, Serhan Özyıldırım, Cem Nazlı, Zeynep Yapan Emren. Evaluation using the Umea 22 questionnaire of quality of life among patients with atrioventricular nodal tachycardia undergoing successful radiofrequency ablation treatment. Turk Kardiyol Dern Ars. 2015; 43(4): 356-360

Corresponding Author: Sadık Volkan Emren, Türkiye
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.